Pediatric Chronic Myeloid Leukemia Treatment in Israel
Pediatric Chronic Myeloid Leukemia: A Rare Malignancy Requiring Expert Care
With expert care, even rare cancers such as pediatric chronic myeloid leukemia are treatable. Read on to learn more about the disease and advanced treatments available in Israel.

Reasons to Seek Treatment for Pediatric Chronic Myeloid Leukemia in Israel
Quality of Care:
Israeli physicians are exceptionally well-trained and often spend even more time on their medical education than American doctors. Also, you can be assured of high standards and strict safety regulations if you choose a hospital accredited by a trustworthy authority.
Cost:
In many countries, healthcare costs can be exorbitant. Without insurance, the costs of cancer treatment can be crippling. Prices are much lower in Israel, averaging 30-80% less than in the US, for example. That said, you’re not trading affordability for quality since Israeli specialists, medical institutions, equipment, and procedures are among the most advanced in the world.
Advanced Treatment:
Medical institutions in Israel and the US often collaborate in advanced cancer research, developing new and effective treatments against the disease, yet Israel has fewer constraints than the US when it comes to adopting novel therapies. Israeli clinical trials still adhere to the highest standards of safety, but innovative treatments are generally made available to patients sooner than in the US.
Request a consultation
Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.
We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.
Request a consultation and a Sheba Case Manager will contact you shortly: